Skip to main content

Gerald Arthur Grant

Allan H. Friedman Distinguished Professor of Neurosurgery
Neurosurgery
Duke Box 3271, Durham, NC 27710
1554A Duke South, Box 3271, Durham, NC 27710

Current Appointments & Affiliations


Allan H. Friedman Distinguished Professor of Neurosurgery · 2023 - Present Neurosurgery, Neurosurgery
Professor of Neurosurgery · 2022 - Present Neurosurgery, Neurosurgery
Chair, Department of Neurosurgery · 2022 - Present Neurosurgery, Neurosurgery
Professor in Neurobiology · 2022 - Present Neurobiology, Basic Science Departments
Professor in Pediatrics · 2023 - Present Pediatrics, Clinical Science Departments
Professor in Neurology · 2024 - Present Neurology, Clinical Science Departments
Member of the Duke Cancer Institute · 2022 - Present Duke Cancer Institute, Institutes and Centers
Faculty Network Member of the Duke Institute for Brain Sciences · 2023 - Present Duke Institute for Brain Sciences, University Institutes and Centers

In the News


Published May 4, 2023
Duke Awards 44 Distinguished Professorships

View All News

Recent Publications


Prediction of seizure risk after repetitive mild traumatic brain injury in childhood.

Journal Article J Neurosurg Pediatr · July 1, 2025 OBJECTIVE: Despite the known negative physiological impact of repeated mild head trauma events, their multiplicative impact on long-term seizure risk remains unclear. The objective of this study was to evaluate how multiple mild traumatic brain injuries (m ... Full text Link to item Cite

Robotic radiosurgery for the treatment of pediatric arteriovenous malformations.

Journal Article J Neurosurg Pediatr · July 1, 2025 OBJECTIVE: Pediatric intracranial arteriovenous malformations (AVMs) have a greater cumulative lifetime risk of rupture than those in adults. Although obliteration after radiation occurs in a dose-dependent manner, increasing radiation doses must be balanc ... Full text Open Access Link to item Cite

BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma.

Journal Article Cell Rep Med · June 17, 2025 Resistance to v-raf murine sarcoma viral oncogene homolog B1 (BRAF) plus mitogen-activated protein kinase kinase (MEK) inhibition (BRAFi+MEKi) in BRAFV600E-mutant gliomas drives rebound, progression, and high mortality, yet it remains poorly understood. Th ... Full text Link to item Cite
View All Publications

Recent Grants


Identification and molecular characterization of somatic mutations in MCD

ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2024 - 2028

A Risk Stratification Model for Health and Academic Outcomes in Children with Concussion Based on Novel Symptom Trajectory Typologies

ResearchSignificant Contributor · Awarded by National Institutes of Health · 2023 - 2028

View All Grants

Education, Training & Certifications


Stanford University · 1994 M.D.